Toll-like receptor 4 (TLR4), which is the main target of LPS, is expressed throughout the body including cardiomyocytes, and it is involved in the etiology of several cardiovascular diseases; for example, cardiac dysfunctions were frequently observed in patients with sepsis and also in animals injected with LPS [45]. This evidence concerns the gene TLR4 and cardiovascular disorder.